Profile data is unavailable for this security.
About the company
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
- Revenue in USD (TTM)392.41m
- Net income in USD175.78m
- Incorporated2008
- Employees599.00
- LocationInmode LtdTavor Building, Sha'ar Yokneam, Pob 533YOKNEAM 2069200IsraelISR
- Phone+972 49097470
- Websitehttps://inmodemd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc | -100.00bn | -100.00bn | 613.06m | 291.00 | -- | -- | -- | -- | -- | -- | -- | 1.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.66 | -- | 0.00 | -- | 442.93 | -- | -24.17 | -- | -- | -- |
| CeriBell Inc | -100.00bn | -100.00bn | 673.34m | 281.00 | -- | 3.70 | -- | -- | -- | -- | -- | 5.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.81 | -- | 0.0979 | -- | 44.71 | -- | -37.30 | -- | -- | -- |
| Owens & Minor Inc | 10.72bn | -365.78m | 711.75m | 13.50k | -- | 1.26 | -- | 0.0664 | -4.75 | -4.75 | 139.19 | 7.39 | 2.13 | 6.67 | 17.15 | 794,092.80 | -7.27 | -0.3346 | -11.85 | -0.5248 | 20.61 | 18.20 | -3.41 | -0.146 | 0.4069 | 1.82 | 0.7733 | -- | 3.55 | 3.04 | -778.15 | -- | 34.30 | -- |
| Iradimed Corp | 75.15m | 19.78m | 782.49m | 160.00 | 39.82 | 8.69 | 38.04 | 10.41 | 1.55 | 1.55 | 5.87 | 7.08 | 0.7922 | 1.49 | 5.84 | 469,716.60 | 20.85 | 14.28 | 22.79 | 15.97 | 76.91 | 76.58 | 26.33 | 22.27 | 7.62 | -- | 0.00 | 66.71 | 11.71 | 13.72 | 11.87 | 14.84 | 78.55 | -- |
| Kestra Medical Technologies Ltd | 45.82m | -93.67m | 783.07m | -- | -- | -- | -- | 17.09 | -1.89 | -1.89 | 0.9251 | 0.5563 | -- | -- | -- | -- | -- | -- | -- | -- | 26.86 | -- | -185.16 | -- | -- | -11.35 | 0.4964 | -- | 264.53 | -- | -16.26 | -- | -- | -- |
| SI-Bone Inc | 176.60m | -26.55m | 785.39m | 349.00 | -- | 4.68 | -- | 4.45 | -0.6358 | -0.6358 | 4.22 | 3.94 | 0.7832 | 1.43 | 7.24 | 506,020.10 | -11.77 | -24.17 | -13.07 | -26.87 | 79.25 | 82.72 | -15.03 | -40.93 | 7.26 | -- | 0.175 | -- | 20.37 | 19.96 | 28.67 | -- | 33.83 | -- |
| STAAR Surgical Co | 279.13m | -71.08m | 869.68m | 1.16k | -- | 2.48 | -- | 3.12 | -1.44 | -1.44 | 5.63 | 7.07 | 0.5877 | 1.67 | 5.34 | 241,256.70 | -14.97 | 3.81 | -17.36 | 4.42 | 74.00 | 77.03 | -25.46 | 5.42 | 4.07 | -- | 0.00 | 0.00 | -2.64 | 15.89 | -194.66 | -- | 18.11 | -- |
| Inmode Ltd | 392.41m | 175.78m | 961.41m | 599.00 | 6.55 | 1.67 | 5.45 | 2.45 | 2.32 | 2.32 | 5.12 | 9.13 | 0.4916 | 1.36 | 11.99 | 655,105.20 | 22.02 | 28.05 | 24.10 | 31.28 | 80.03 | 83.39 | 44.80 | 40.99 | 7.86 | -- | 0.00 | 0.00 | -19.76 | 20.35 | -8.41 | 24.28 | -0.7024 | -- |
| Pulse Biosciences Inc | 0.00 | -60.24m | 1.03bn | 75.00 | -- | 8.70 | -- | -- | -0.9691 | -0.9691 | 0.00 | 1.76 | 0.00 | -- | -- | 0.00 | -66.00 | -83.75 | -71.00 | -94.40 | -- | -- | -- | -12,644.52 | 15.58 | -- | 0.00 | -- | -- | -- | -26.95 | -- | -27.12 | -- |
| Integra Lifesciences Holdings Corp | 1.62bn | -28.96m | 1.05bn | 4.40k | -- | 0.6894 | 8.86 | 0.6468 | -0.3767 | -0.3767 | 21.18 | 19.61 | 0.3995 | 1.59 | 6.58 | 369,496.80 | -0.7122 | 2.90 | -0.838 | 3.25 | 58.47 | 62.59 | -1.78 | 7.14 | 0.7206 | 2.98 | 0.5474 | 0.00 | 4.47 | 1.20 | -110.25 | -- | -3.19 | -- |
| BioLife Solutions Inc | 94.24m | -7.62m | 1.08bn | 159.00 | -- | 3.07 | 7,514.00 | 11.48 | -0.1658 | -0.2297 | 2.03 | 7.42 | 0.2366 | 0.992 | 6.79 | 592,729.60 | -1.91 | -1.92 | -2.09 | -2.10 | 62.64 | 52.54 | -8.09 | -9.06 | 3.74 | -1.06 | 0.0354 | -- | 8.44 | 24.62 | 38.27 | -- | 19.15 | -- |
| Neogen Corp | 906.00m | -485.26m | 1.14bn | 2.92k | -- | 0.4267 | -- | 1.25 | -2.24 | -2.24 | 4.18 | 12.26 | 0.2102 | 2.39 | 5.43 | 310,591.70 | -11.26 | 1.38 | -11.67 | 1.44 | 48.79 | 48.23 | -53.56 | 4.31 | 2.45 | 0.88 | 0.2513 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Tandem Diabetes Care Inc | 982.95m | -183.87m | 1.14bn | 2.65k | -- | 7.32 | -- | 1.16 | -2.78 | -2.78 | 14.96 | 2.33 | 1.06 | 3.18 | 8.96 | 370,924.90 | -19.74 | -10.11 | -26.61 | -12.33 | 52.22 | 51.67 | -18.71 | -11.71 | 1.81 | -- | 0.6953 | -- | 25.74 | 21.01 | 56.86 | -- | 27.42 | -- |
| Adapthealth Corp | 3.25bn | 78.62m | 1.26bn | 10.50k | 16.21 | 0.8065 | 2.70 | 0.3895 | 0.5779 | 0.5779 | 23.91 | 11.62 | 0.7262 | 20.92 | 7.66 | 309,177.20 | 2.01 | -2.81 | 2.29 | -3.17 | 23.35 | 19.63 | 2.77 | -4.19 | 1.07 | 2.24 | 0.5596 | -- | 1.90 | 43.84 | 112.19 | -- | 70.36 | -- |
| Establishment Labs Holdings Inc | 170.24m | -89.10m | 1.28bn | 1.03k | -- | 33.27 | -- | 7.54 | -3.10 | -3.10 | 5.94 | 1.33 | 0.536 | 0.7032 | 2.98 | 167,225.00 | -28.06 | -31.53 | -34.39 | -39.32 | 66.35 | 65.46 | -52.34 | -45.09 | 2.05 | -2.41 | 0.8511 | -- | 0.5292 | 13.14 | -7.76 | -- | 17.33 | -- |
| BioSig Technologies Inc | 26.00k | -9.79m | 1.32bn | 5.00 | -- | 89.83 | -- | 50,612.27 | -0.6236 | -0.6236 | 0.0016 | 0.1118 | 0.0087 | -- | 0.4228 | 5,200.00 | -323.76 | -266.73 | -- | -392.02 | 50.00 | -- | -37,400.00 | -20,163.95 | -- | -1,551.13 | 0.00 | -- | 122.22 | -- | 63.81 | -- | -- | -- |
Data as of Jul 03 2025. Currency figures normalised to Inmode Ltd's reporting currency: US Dollar USD
28.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2025 | 4.91m | 7.06% |
| Renaissance Technologies LLCas of 31 Mar 2025 | 2.31m | 3.32% |
| DOMA Perpetual Capital Management LLCas of 31 Mar 2025 | 2.24m | 3.22% |
| LSV Asset Managementas of 31 Mar 2025 | 2.01m | 2.89% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 1.83m | 2.63% |
| UBS Switzerland AG (Investment Management)as of 31 Mar 2025 | 1.47m | 2.11% |
| Boston Trust Walden, Inc.as of 31 Mar 2025 | 1.37m | 1.96% |
| Meitav Mutual Funds Ltd.as of 31 Mar 2025 | 1.33m | 1.91% |
| Systematic Financial Management LPas of 31 Mar 2025 | 1.05m | 1.51% |
| DDD Partners LLCas of 31 Mar 2025 | 989.90k | 1.42% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
